LP15937-3
Ampicillin+Sulbactam
Active
Description
Ampicillin/sulbactam is a combination of the common penicillin-derived antibiotic ampicillin and sulbactam, an inhibitor of bacterial beta-lactamase. Two different forms of the drug exist. The first, developed in 1987 and marketed in the United States under the tradename Unasyn, is an intravenous antibiotic. The second, an oral form called sultamicillin, is marketed under the trade name Ampictam outside of the United States. Ampicillin/sulbactam is used to treat infections caused by bacteria resistant to beta-lactam antibiotics. Sulbactam blocks the enzyme which breaks down ampicillin and thereby allows ampicillin to attack and kill the bacteria. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Ampicillin+Sulbactam
Basic Part Properties
- Part Display Name
- Ampicillin+Sulbactam
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2000-05-04
- Construct for LOINC Short Name
- Ampicillin+Sulbac
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP15937-3
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
zh-CN | Chinese (China) | 氨苄青霉素+舒巴坦 |
fr-CA | French (Canada) | Ampicilline+sulbactame Synonyms: #REF! |
et-EE | Estonian (Estonia) | Ampitsilliin + sulbaktaam |
es-ES | Spanish (Spain) | Ampicilina + Sulbactam |
it-IT | Italian (Italy) | Ampicillina+Sulbactam |
tr-TR | Turkish (Turkey) | Ampisilin+sulbaktam |
ru-RU | Russian (Russian Federation) | Ампициллин+Сульбактам |
nl-NL | Dutch (Netherlands) | ampicilline + sulbactam |
fr-BE | French (Belgium) | Ampicilline+sulbactame |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright